These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8043483)

  • 81. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
    Malaguti M; Capece R; Marciano M; Arena G; Luciani MP; Striano M; Biagini M
    Nephron; 1992; 61(3):346. PubMed ID: 1323786
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Hepatitis C in hemophiliac patients in Maracaibo, Venezuela].
    Arteaga-Vizcaíno M; Blitz-Dorfman L; Echeverría JM; León P; Weir-Medina J; Diez-Ewald M; Vizcaíno G; Torres E; Porto-Espinoza L
    Invest Clin; 1993; 34(3):113-8. PubMed ID: 7512388
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients.
    Mihaljević I; Feldbauer J; Delajlija M; Grgicević D
    Vox Sang; 1992; 63(3):236. PubMed ID: 1333138
    [No Abstract]   [Full Text] [Related]  

  • 84. [Prevalence of antibodies against hepatitis C virus in HIV positive subjects from different risk groups].
    García Samaniego J; Enríquez A; Soriano V; Muñoz F
    Med Clin (Barc); 1992 Sep; 99(9):357-8. PubMed ID: 1435012
    [No Abstract]   [Full Text] [Related]  

  • 85. Prevalence of hepatitis C virus antibodies in renal transplant patients.
    Chaudhary RK; Rossier E
    Can Dis Wkly Rep; 1991 Mar; 17(10):53-4. PubMed ID: 1709831
    [No Abstract]   [Full Text] [Related]  

  • 86. [Prevalence of anti-hepatitis C antibody carriers in a military population engaged in overseas missions].
    Martet G; Merouze F; Thomas C; Morillon M; Klotz F; Laroche R
    Med Trop (Mars); 1994; 54(1):88. PubMed ID: 7515143
    [No Abstract]   [Full Text] [Related]  

  • 87. [Reduction of the proportion of anti-HCV-positive donations].
    Quiles FJ; Sanz A; Cabanillas A; Sáenz P; Sánchez GM; Díaz F
    Sangre (Barc); 1992 Apr; 37(2):153-4. PubMed ID: 1320294
    [No Abstract]   [Full Text] [Related]  

  • 88. Hepatitis C virus infection in kidney transplant recipients.
    Valeri M; Pisani F; De Paolis P; Piazza A; Torlone N; Utzeri G; Elli M; Tisone G; Adorno D; Casciani CU
    Transplant Proc; 1993 Jun; 25(3):2284-5. PubMed ID: 7685948
    [No Abstract]   [Full Text] [Related]  

  • 89. [The hepatitis C viral infection of the medical workers and patients at hemodialysis units in Moscow].
    Sychev AV; Mikhaĭlov MI
    Vopr Virusol; 1993; 38(3):105-7. PubMed ID: 8073748
    [TBL] [Abstract][Full Text] [Related]  

  • 90. High prevalence of hepatitis C virus among urban and rural population groups in Egypt.
    el Gohary A; Hassan A; Nooman Z; Lavanchy D; Mayerat C; el Ayat A; Fawaz N; Gobran F; Ahmed M; Kawano F
    Acta Trop; 1995 May; 59(2):155-61. PubMed ID: 7545863
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Is liver involvement of beta thalassaemic children related to the presence of hepatitis C virus antibodies?
    Ozsoylu S
    Eur J Pediatr; 1993 Jun; 152(6):538-9. PubMed ID: 7687547
    [No Abstract]   [Full Text] [Related]  

  • 92. [Changes in the prevalence of anti-HCV in blood donors in Asturias].
    Suárez A; San Román F; Rodríguez M; Rodrigo L
    Med Clin (Barc); 1992 Oct; 99(13):515. PubMed ID: 1434977
    [No Abstract]   [Full Text] [Related]  

  • 93. [Hepatitis C virus].
    Garassini MA
    G E N; 1990; 44(1):67-70. PubMed ID: 1967084
    [No Abstract]   [Full Text] [Related]  

  • 94. High prevalence of hepatitis C virus antibodies in a local haemophiliac population.
    du Toit JM; Brink NS; Bird AR; Robson SC; Jacobs P
    S Afr Med J; 1991 Sep; 80(6):285-6. PubMed ID: 1656535
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [The importance of the blood transfusion factor in the epidemic process in hepatitis C in the patients of chronic hemodialysis units studied using a computer simulation model].
    Savin EA; Kuzin SN; Blinov VM; Loparev VN; Sukhanova LL; Gol'tsov VA; Ershova GN; Viazov SO; Shakhgil'dian IV
    Vopr Virusol; 1993; 38(3):135-7. PubMed ID: 8073753
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Cooleycare Group.
    Rebulla P; Mozzi F; Contino G; Locatelli E; Sirchia G
    Transfus Med; 1992 Mar; 2(1):69-70. PubMed ID: 1284983
    [No Abstract]   [Full Text] [Related]  

  • 97. The risk for hepatitis C infection in blood donors in Cluj County, Romania.
    Hâţu G; Brumboiu MI; Czernichow P; Bocşan IS
    Transfus Clin Biol; 2014 May; 21(2):94-7. PubMed ID: 24797791
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Seroprevalence of the hepatitis C virus in donors and in high and low risk groups in Salamanca].
    Martín AM; Canut A; Corral M; Cordero M
    Med Clin (Barc); 1992 May; 98(17):676-7. PubMed ID: 1598016
    [No Abstract]   [Full Text] [Related]  

  • 99. Further insights into hepatitis C.
    Colombo M
    Ital J Gastroenterol; 1991 Dec; 23(9):574-5. PubMed ID: 1662092
    [No Abstract]   [Full Text] [Related]  

  • 100. Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Trent Regional Hepatitis C Virus Study Group.
    Irving WL; Neal KR; Underwood JC; Simmonds PN; James V
    BMJ; 1994 Mar; 308(6930):695-6. PubMed ID: 8142794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.